Parallax Volatility Advisers’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-353,227
| Closed | -$30.1K | – | 1201 |
|
|
2023
Q2 | $30.1K | Sell |
353,227
-72,152
| -17% | -$6.15K | ﹤0.01% | 576 |
|
|
2023
Q1 | $17K | Sell |
425,379
-23,907
| -5% | -$956 | ﹤0.01% | 658 |
|
|
2022
Q4 | $12.4K | Sell |
449,286
-379,522
| -46% | -$10.5K | ﹤0.01% | 703 |
|
|
2022
Q3 | $47K | Buy |
828,808
+238,201
| +40% | +$13.5K | ﹤0.01% | 764 |
|
|
2022
Q2 | $53K | Buy |
590,607
+159,522
| +37% | +$14.3K | ﹤0.01% | 781 |
|
|
2022
Q1 | $155K | Buy |
431,085
+107,943
| +33% | +$38.8K | ﹤0.01% | 693 |
|
|
2021
Q4 | $162K | Buy |
+323,142
| New | +$162K | ﹤0.01% | 514 |
|